Showing results (1641-1650 of 3,313) with videos related to

Sort By:
Pageof 332
Transfusion|September 11, 2016
Very low rate of patient-related adverse events associated with the use of intraoperative cell salvageDiana DeAndrade, Jonathan H Waters, Darrell J Triulzi, et al.
The New Phytologist|November 25, 2021
Evidence for host-microbiome co-evolution in appleAhmed Abdelfattah, Ayco J M Tack, Birgit Wasserman, et al.
Social Cognitive and Affective Neuroscience|December 1, 2021
Dynamic computation of value signals via a common neural network in multi-attribute decision-makingAmadeus Magrabi, Vera U Ludwig, Christian M Stoppel, et al.
Journal of Biomolecular Screening|June 21, 2005
Cell-based assays to detect inhibitors of fungal mRNA capping enzymes and characterization of sinefungin as a cap methyltransferase inhibitorGary L Chrebet, Douglas Wisniewski, Ann L Perkins, et al.
Journal of the American Dental Association (1939)|January 1, 1988
The prevalence of smokeless tobacco use among adolescent male athletesC J Creath, W O Shelton, J T Wright, et al.
Infection Control and Hospital Epidemiology|January 1, 2004
Electronic interpretation of chest radiograph reports to detect central venous cathetersWilliam E Trick, Wendy W Chapman, Mary F Wisniewski, et al.
Critical Care Medicine|August 2, 2000
Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failureM J Whalen, L A Doughty, T M Carlos, et al.
Neurosurgery|September 24, 1999
Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approachE I Levy, A D Firlik, S Wisniewski, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancyM A Syed, M J Horwitz, M B Tedesco, et al.
Rheumatology (Oxford, England)|January 28, 2021
Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial designRobyn T Domsic, Shiyao Gao, Maureen Laffoon, et al.
Pageof 332